(5E)-5-(2-hydroxy-3-methoxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g

ethyl 3-(2-chloro-5-nitropyridin-4-yl)-2-hydroxyprop-2-enoate, 95%, 1g

1-Methyl-1H-pyrazol-4-ylamine hydrochloride, 95.0%, 25g

4,4,5,5-Tetramethyl-2-(tetrahydro-2H-pyran-4-yl)-1,3,2-dioxaborolane, 95.0%, 250mg

2-Bromo-5-(methoxycarbonyl)benzoic acid, 97%, 250mg

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 250mg

Sample vials ROTILABO® with thread ND10, Clear glass, with labelling space, 100 Piece(s)

1-BROMO-4-FLUOROISOQUINOLINE, 95.0%, 100mg

(3-(2-Cyanopropan-2-yl)phenyl)boronic acid, 95.0%, 1g

Indolin-6-ol, 95.0%, 100mg

3-(Trifluoromethyl)thiobenzamide, 98.0%, 1g

Tetracontane>97.0%(GC)1g

1,3-Bis(2,6-diisopropylphenyl)imidazolium Chloride>98.0%(HPLC)(T)5g